KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Gastroenterology / 2020 / Cilt: 31 - Sayı: 12

Low-dose aspirin and the severity of ıschemic colitis: A single-center retrospective study

Weiming XIAO
Shuaiyang ZHOU
Keyan WU
Bin DENG
Dacheng WU
Yuanzhi WANG
Weijuan GONG
Yanbing DING
Guotao LU
Sayfa
848–852
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Colonoscopy results showed that the incidenceof ulceration was significantly higher in the aspirin group than in the non-aspirin group (p<0.05).Conclusion: The use of low-dose aspirin may aggravate the severity and mask the symptoms of abdominal pain in ischemic colitis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aims: This retrospective study aimed to evaluate the effect of low-dose aspirin (50-150 mg/d) on the severity of ischemiccolitis.Materials and Methods: A total of 244 patients admitted to our hospital for ischemic colitis between 2013 and 2018 were included inthe study.
📊
Temel Bulgular & Veri:Clinical performance, biochemical indices, and endoscopic findings were compared.Results: The average age and the proportion of underlying disease, including hypertension, cerebral infarction, and coronary heart disease in the aspirin group was significantly higher than those in the non-aspirin group (p<0.05).
💡
Sonuç & Katkı:Colonoscopy results showed that the incidenceof ulceration was significantly higher in the aspirin group than in the non-aspirin group (p<0.05).Conclusion: The use of low-dose aspirin may aggravate the severity and mask the symptoms of abdominal pain in ischemic colitis.
🔬Tür:Araştırma Makalesi
📍Kapsam:2013 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims: This retrospective study aimed to evaluate the effect of low-dose aspirin (50-150 mg/d) on the severity of ischemiccolitis.Materials and Methods: A total of 244 patients admitted to our hospital for ischemic colitis between 2013 and 2018 were included inthe study. Patients were divided into two groups—aspirin and non-aspirin groups—based on their recent history of aspirin use before theonset of ischemic colitis. Clinical performance, biochemical indices, and endoscopic findings were compared.Results: The average age and the proportion of underlying disease, including hypertension, cerebral infarction, and coronary heart disease in the aspirin group was significantly higher than those in the non-aspirin group (p<0.05). In terms of clinical symptoms, the proportion of diarrhea in the aspirin group was significantly higher than that in the non-aspirin group, while the proportion of abdominalpain was significantly lower in the aspirin group compared with the non-aspirin group. Colonoscopy results showed that the incidenceof ulceration was significantly higher in the aspirin group than in the non-aspirin group (p<0.05).Conclusion: The use of low-dose aspirin may aggravate the severity and mask the symptoms of abdominal pain in ischemic colitis.

🔖

Bu Makaleye Atıf Yap

XIAO, W., ZHOU, S., WU, K., DENG, B., WU, D., WANG, Y., GONG, W., DING, Y., LU, G. (2020). Low-dose aspirin and the severity of ıschemic colitis: A single-center retrospective study. Turkish Journal of Gastroenterology, Cilt: 31 - Sayı: 12, 848–852. https://ajindex.com/articles/409232

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Lo WK, Mahboobani NR, Siu Y, et al. Gastrointestinal: Phlebosclerotic colitis: A rare but increasingly recognized cause of ischemic colitis with telltale imaging features. Gastroenterol Hepatol 2017; 32: 1792
  2. AL Nikolic, JO Keck. Ischaemic colitis: uncertainty in diagnosis, pathophysiology and management. Anz J Surg 2017
  3. Liu W, Liao L, Shi H, et al. An analysis of clinical characteristics and risk factors for ulceration in ischemic colitis. Zhonghua Nei Ke Za Zhi 2014; 53: 626-30
  4. O’Neill S, Yalamarthi S. Systematic review of the management of ischaemic colitis. Colorectal Dis 2012; 14: e751-63
  5. Kimura T, Shinji A, Horiuchi A, et al. Clinical characteristics of young-onset ischemic colitis. Dig Diseases and Sciences 2012; 57: 1652-9
  6. Mosińska P, Fichna J. Ischemic Colitis: Current Diagnosis and Treatment. Curr Drug Targets 2015; 16: 209-18
  7. Dalbeni A, Capoferro E, Bernardoni L, et al. Pancolitis with ischemic injury as a complication of immunosuppressive treatment in a patient with autoimmune hepatitis: a case report. Case Rep Gastrointest Med 2012; 2012: 698404
  8. Peixoto A, Silva M, Gaspar R, et al. Predictive factors of short-term mortality in ischaemic colitis and development of a new prognostic scoring model of in-hospital mortality. United European Gastroenterol J 2017; 5: 432-9
  9. Sadler MD, Ravindran NC, Hubbard J, et al. Predictors of mortality among patients undergoing colectomy for ischemic colitis: A population-based United States study. Can J Gastroenterol Hepatol 2014; 28: 600-4
  10. Feuerstadt P, Brandt LJ. Update on Colon Ischemia: Recent Insights and Advances. Curr Gastroenterol Rep 2015; 17: 45
  11. Misiakos EP, Tsapralis D, Karatzas T, et al. Advents in the Diagnosis and Management of Ischemic Colitis. Front Surg 2017; 4: 47
  12. Sun D, Wang C, Yang L, et al.The predictors of the severity of ischaemic colitis: a systematic review of 2,823 patients from 22 studies. Colorectal Dis 2016; 18: 949-58
  13. Martínez JM, Molano JV, Henao SR. Gastroduodenal mucosal injuries by aspirine. Management of the risks. Rev Gastroenterol Peru 2016; 36: 129-34
  14. Moore N, Scheiman JM. Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesics. Postgrad Med 2018; 130: 188-99
  15. Reyes-Zamorano J. Colonic necrosis and stricture due tonon-occlusive ischemic colitis. Report of two cases and review of the literature. Cir Cir 2014; 82: 442-7
  16. Doulberis M, Panagopoulos P, Scherz S, et al.Update on isch